Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases

Publisher： John Wiley & Sons Inc

E-ISSN： 1445-2197|88|1-2|E16-E20

ISSN： 1445-1433

Source： ANZ JOURNAL OF SURGERY, Vol.88, Iss.1-2, 2018-01, pp. : E16-E20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful Neoadjuvant Chemotherapy of Nonresectable Colorectal Liver Metastases: An Interdisciplinary Approach

By  

Oncology Research and Treatment, Vol. 22, Iss. 1, 1999-03 ,pp. : 54-56

Karger

Access to resources Recommend Favorite

Cetuximab in Combination with 5-Fluorouracil, Leucovorin and Irinotecan as a Neoadjuvant Chemotherapy in Patients with Initially Unresectable Colorectal Liver Metastases

By  

Oncology Research and Treatment, Vol. 30, Iss. 12, 2007-11 ,pp. : 637-643

Karger

Access to resources Recommend Favorite

Proposal for novel histological findings of colorectal liver metastases with preoperative chemotherapy

By  

PATHOLOGY INTERNATIONAL, Vol. 65, Iss. 7, 2015-07 ,pp. : 367-373

John Wiley & Sons Inc

Access to resources Recommend Favorite

The impact of portal pedicle clamping on survival from colorectal liver metastases in the contemporary era of liver resection: a matched cohort study

By  

HPB, Vol. 17, Iss. 9, 2015-09 ,pp. : 796-803

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of neoadjuvant chemotherapy in resectable synchronous colorectal liver metastasis; An international multi‐center data analysis using LiverMetSurvey

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 6, 2015-05 ,pp. : 716-724

John Wiley & Sons Inc

Access to resources Recommend Favorite